{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T22:44:39Z","timestamp":1790808279842,"version":"4.1.0"},"reference-count":122,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,1,22]],"date-time":"2020-01-22T00:00:00Z","timestamp":1579651200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004099","name":"Ligue Contre le Cancer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004099","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004431","name":"Fondation de France","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004431","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007391","name":"Association pour la Recherche sur le Cancer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007391","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"DOI":"10.3389\/fonc.2019.01443","type":"journal-article","created":{"date-parts":[[2020,1,22]],"date-time":"2020-01-22T05:48:55Z","timestamp":1579672135000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":25,"title":["Upcoming Revolutionary Paths in Preclinical Modeling of Pancreatic Adenocarcinoma"],"prefix":"10.3389","volume":"9","author":[{"given":"Mirna","family":"Swayden","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Soubeyran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Iovanna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2020,1,22]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"111","DOI":"10.2353\/jmoldx.2008.070115","article-title":"Molecular genetics of pancreatic ductal adenocarcinomas and recent implications for translational efforts","volume":"10","author":"Feldmann","year":"2008","journal-title":"J Mol Diagn."},{"key":"B2","doi-asserted-by":"publisher","first-page":"1605","DOI":"10.1056\/NEJMra0901557","article-title":"Pancreatic cancermedical progress","volume":"362","author":"Hidalgo","year":"2010","journal-title":"N Engl J Med."},{"key":"B3","doi-asserted-by":"publisher","first-page":"2913","DOI":"10.1158\/0008-5472.CAN-14-0155","article-title":"Projecting cancer incidence and deaths to 2030: the unexpected burden of thyroid, liver, and pancreas cancers in the United States","volume":"74","author":"Rahib","year":"2014","journal-title":"Cancer Res."},{"key":"B4","doi-asserted-by":"publisher","first-page":"917","DOI":"10.2217\/fon.13.76","article-title":"The rise and fall of cancer mortality in the USA: why does pancreatic cancer not follow the trend?","volume":"9","author":"Ma","year":"2013","journal-title":"Future Oncol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1093\/annonc\/mds313","article-title":"New insights into pancreatic cancer biology","volume":"23","author":"Hidalgo","year":"2012","journal-title":"Ann Oncol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1159\/000199433","article-title":"Medical management of pancreatic adenocarcinoma","volume":"9","author":"Freitas","year":"2009","journal-title":"Pancreatology."},{"key":"B7","doi-asserted-by":"publisher","first-page":"2403","DOI":"10.1200\/JCO.1997.15.6.2403","article-title":"Improvements in survival and clinical benefit with gemcitabine as first- line therapy for patients with advanced pancreas cancer: a randomized trial","volume":"15","author":"Burris","year":"1997","journal-title":"J Clin Oncol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"1817","DOI":"10.1056\/NEJMoa1011923","article-title":"FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer","volume":"364","author":"Conroy","year":"2011","journal-title":"N Engl J Med."},{"key":"B9","doi-asserted-by":"publisher","first-page":"1691","DOI":"10.1056\/NEJMoa1304369","article-title":"Increased survival in pancreatic cancer with nab-paclitaxel plus gemcitabine","volume":"369","author":"Von Hoff","year":"2013","journal-title":"N Engl J Med."},{"key":"B10","first-page":"25","article-title":"FDA and clinical drug trials: a short history","author":"Junod","year":"2008","journal-title":"A Quick Guide to Clinical Trials For People Who May Not Know it All"},{"key":"B11","doi-asserted-by":"publisher","first-page":"1679","DOI":"10.1016\/j.drudis.2014.06.003","article-title":"Drug development and discovery: challenges and opportunities","volume":"19","author":"Moridani","year":"2014","journal-title":"Drug Discov Today."},{"key":"B12","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1586\/17512433.2015.1034690","article-title":"What lessons can be learned from failed Alzheimer's disease trials?","volume":"8","author":"Toyn","year":"2015","journal-title":"Expert Rev Clin Pharmacol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1007\/s10555-013-9450-8","article-title":"Why anti-Bcl-2 clinical trials fail: a solution","volume":"33","author":"Harazono","year":"2014","journal-title":"Cancer Metastasis Rev."},{"key":"B14","first-page":"1173","article-title":"Establishment and characteristics of cell strains from some epithelial tumors of human origin","volume":"31","author":"Dobrynin Y","year":"1963","journal-title":"J Natl Cancer Inst."},{"key":"B15","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.trecan.2016.03.004","article-title":"Modeling pancreatic cancer with organoids","volume":"2","author":"Baker","year":"2016","journal-title":"Trends Cancer."},{"key":"B16","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1016\/j.jcmgh.2017.12.004","article-title":"Pancreas 3D organoids: current and future aspects as a research platform for personalized Cell Mol Gastroenterol Hepatol","volume":"5","author":"Moreira","year":"2018"},{"key":"B17","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/j.ccr.2006.03.030","article-title":"Tumor stem cells derived from glioblastomas cultured in bFGF and EGF more closely mirror the phenotype and genotype of primary tumors than do serum-cultured cell lines","volume":"9","author":"Lee","year":"2006","journal-title":"Cancer Cell."},{"key":"B18","doi-asserted-by":"publisher","first-page":"7900","DOI":"10.1093\/nar\/gkr533","article-title":"A global insight into a cancer transcriptional space using pancreatic data: importance, findings and flaws","volume":"39","author":"Gadaleta","year":"2011","journal-title":"Nucleic Acids Res."},{"key":"B19","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1038\/nrc1098","article-title":"The pathogenesis of cancer metastasis: the seed and soil hypothesis revisited","volume":"3","author":"Fidler","year":"2003","journal-title":"Nat Rev Cancer."},{"key":"B20","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1016\/j.ccr.2005.04.023","article-title":"Trp53R172H and KrasG12D cooperate to promote chromosomal instability and widely metastatic pancreatic ductal adenocarcinoma in mice","volume":"7","author":"Hingorani","year":"2005","journal-title":"Cancer Cell."},{"key":"B21","doi-asserted-by":"publisher","first-page":"1457","DOI":"10.1126\/science.1171362","article-title":"Inhibition of Hedgehog signaling enhances delivery of chemotherapy in a mouse model of pancreatic cancer","volume":"324","author":"Olive","year":"2009","journal-title":"Science."},{"key":"B22","doi-asserted-by":"publisher","first-page":"20212","DOI":"10.1073\/pnas.1320318110","article-title":"Targeting CXCL12 from FAP-expressing carcinoma-associated fibroblasts synergizes with anti-PD-L1 immunotherapy in pancreatic cancer","volume":"110","author":"Feig","year":"2013","journal-title":"Proc Natl Acad Sci USA"},{"key":"B23","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1016\/j.ccr.2014.04.005","article-title":"Depletion of carcinoma-associated fibroblasts and fibrosis induces immunosuppression and accelerates pancreas cancer with reduced survival","volume":"25","author":"\u00d6zdemir","year":"2014","journal-title":"Cancer Cell."},{"key":"B24","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1016\/j.ccr.2014.04.021","article-title":"Stromal elements act to restrain, rather than support, pancreatic ductal adenocarcinoma","volume":"25","author":"Rhim","year":"2014","journal-title":"Cancer Cell."},{"key":"B25","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1038\/s41586-019-1608-2","article-title":"The fungal mycobiome promotes pancreatic oncogenesis via activation of MBL","volume":"574","author":"Aykut","year":"2019","journal-title":"Nature."},{"key":"B26","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1016\/j.cell.2019.07.008","article-title":"Tumor microbiome diversity and composition influence pancreatic cancer outcomes","volume":"178","author":"Riquelme","year":"2019","journal-title":"Cell."},{"key":"B27","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1101\/gad.2016111","article-title":"Pancreatic cancers require autophagy for tumor growth","volume":"25","author":"Yang","year":"2011","journal-title":"Genes Dev."},{"key":"B28","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1158\/1078-0432.CCR-14-1591","article-title":"Combined MEK and PI3K inhibition in a mouse model of pancreatic cancer","volume":"21","author":"Alagesan","year":"2015","journal-title":"Clin Cancer Res."},{"key":"B29","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1007\/s40139-015-0086-y","article-title":"Mouse models as predictors of human responses: evolutionary medicine","volume":"3","author":"Uhl","year":"2015","journal-title":"Curr Pathobiol Rep."},{"key":"B30","doi-asserted-by":"publisher","first-page":"2731","DOI":"10.4049\/jimmunol.172.5.2731","article-title":"Of mice and not men: differences between mouse and human immunology","volume":"172","author":"Mestas","year":"2004","journal-title":"J Immunol."},{"key":"B31","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1053\/j.seminhematol.2013.03.030","article-title":"Telomere dynamics in mice and humans","volume":"50","author":"Calado","year":"2013","journal-title":"Semin Hematol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1038\/nature11547","article-title":"Pancreatic cancer genomes reveal aberrations in axon guidance pathway genes","volume":"491","author":"Biankin","year":"2012","journal-title":"Nature."},{"key":"B33","doi-asserted-by":"publisher","first-page":"e77065","DOI":"10.1371\/journal.pone.0077065","article-title":"Clinical, molecular and genetic validation of a murine orthotopic xenograft model of pancreatic adenocarcinoma using fresh human specimens","volume":"8","author":"Walters","year":"2013","journal-title":"PLoS ONE."},{"key":"B34","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1038\/nrc2192","article-title":"Maximizing mouse cancer models","volume":"7","author":"Frese","year":"2007","journal-title":"Nat Rev Cancer."},{"key":"B35","doi-asserted-by":"publisher","first-page":"4266","DOI":"10.1158\/1078-0432.CCR-11-3114","article-title":"The pancreas cancer microenvironment tumor microenvironment","volume":"18","author":"Feig","year":"2012","journal-title":"Clin Cancer Res."},{"key":"B36","doi-asserted-by":"publisher","first-page":"1424","DOI":"10.1054\/bjoc.2001.1796","article-title":"Relationships between drug activity in NCI preclinical in vitro and in vivo models and early clinical trials","volume":"84","author":"Johnson","year":"2001","journal-title":"Br J Cancer."},{"key":"B37","doi-asserted-by":"publisher","first-page":"3605","DOI":"10.1200\/JCO.2009.25.7550","article-title":"Phase III study comparing gemcitabine plus cetuximab versus gemcitabine in patients with advanced pancreatic adenocarcinoma: southwest oncology group-directed intergroup trial S0205","volume":"28","author":"Philip","year":"2010","journal-title":"J Clin Oncol."},{"key":"B38","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1097\/00006676-200410000-00004","article-title":"Orthotopic transplantation models of pancreatic adenocarcinoma derived from cell lines and primary tumors and displaying varying metastatic activity","volume":"29","author":"Loukopoulos","year":"2004","journal-title":"Pancreas."},{"key":"B39","doi-asserted-by":"publisher","first-page":"5645","DOI":"10.1073\/pnas.89.12.5645","article-title":"A metastatic nude-mouse model of human pancreatic cancer constructed orthotopically with histologically intact patient specimens","volume":"89","author":"Fu","year":"2006","journal-title":"Proc Natl Acad Sci USA."},{"key":"B40","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1093\/jnci\/djn481","article-title":"From human to mouse and back: Tumorgraft models surge in popularity","volume":"101","author":"Garber","year":"2009","journal-title":"J Natl Cancer Inst."},{"key":"B41","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.1158\/1535-7163.MCT-11-0233","article-title":"A pilot clinical study of treatment guided by personalized tumorgrafts in patients with advanced cancer","volume":"10","author":"Hidalgo","year":"2011","journal-title":"Mol Cancer Ther."},{"key":"B42","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1016\/j.ajpath.2014.11.029","article-title":"Transcriptomic analysis predicts survival and sensitivity to anticancer drugs of patients with a pancreatic adenocarcinoma","volume":"185","author":"Duconseil","year":"2015","journal-title":"Am J Pathol."},{"key":"B43","doi-asserted-by":"publisher","first-page":"482","DOI":"10.15252\/emmm.201606975","article-title":"Gene expression profiling of patient-derived pancreatic cancer xenografts predicts sensitivity to the BET bromodomain inhibitor JQ1: implications for individualized medicine efforts","volume":"9","author":"Bian","year":"2017","journal-title":"EMBO Mol Med."},{"key":"B44","doi-asserted-by":"publisher","first-page":"1114","DOI":"10.1038\/nature09515","article-title":"Distant metastasis occurs late during the genetic evolution of pancreatic cancer","volume":"467","author":"Yachida","year":"2010","journal-title":"Nature."},{"key":"B45","doi-asserted-by":"publisher","first-page":"2458","DOI":"10.1016\/j.celrep.2017.11.003.","article-title":"Pancreatic adenocarcinoma therapeutic targets revealed by tumor-stroma cross-talk analyses in patient-derived xenografts","volume":"21","author":"Nicolle","year":"2017","journal-title":"Cell Rep."},{"key":"B46","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1038\/nrc3944","article-title":"Examining the utility of patient-derived xenograft mouse models","volume":"15","author":"Aparicio","year":"2015","journal-title":"Nat Rev Cancer."},{"key":"B47","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.1016\/j.ajpath.2015.01.016","article-title":"Patient-derived xenograft models for pancreatic adenocarcinoma demonstrate retention of tumor morphology through incorporation of murine stromal elements","volume":"185","author":"Delitto","year":"2015","journal-title":"Am J Pathol."},{"key":"B48","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1158\/2159-8290.CD-14-0001","article-title":"Patient-derived xenograft models: an emerging platform for translational cancer research","volume":"4","author":"Hidalgo","year":"2014","journal-title":"Cancer Discov."},{"key":"B49","doi-asserted-by":"publisher","first-page":"78396","DOI":"10.18632\/oncotarget.11893","article-title":"Unique metabolic features of pancreatic cancer stroma: relevance to the tumor compartment, prognosis, and invasive potential","volume":"7","author":"Knudsen","year":"2016","journal-title":"Oncotarget."},{"key":"B50","doi-asserted-by":"publisher","first-page":"2476","DOI":"10.1038\/s41598-017-02823-9","article-title":"Efficient generation of bispecific murine antibodies for pre-clinical investigations in syngeneic rodent models","volume":"7","author":"Labrijn","year":"2017","journal-title":"Sci Rep."},{"key":"B51","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1038\/s41586-019-1711-4","article-title":"Search-and-replace genome editing without double-strand breaks or donor DNA","volume":"576","author":"Anzalone","year":"2019","journal-title":"Nature."},{"key":"B52","doi-asserted-by":"publisher","first-page":"1734","DOI":"10.1126\/science.271.5256.1734","article-title":"Enhancement of antitumor immunity by CTLA-4 blockade","volume":"271","author":"Leach","year":"1996","journal-title":"Science."},{"key":"B53","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1038\/nm0902-1039c","article-title":"Tumor-associated B7-H1 promotes T-cell apoptosis: a potential mechanism of immune evasion","volume":"8","author":"Dong","year":"2002","journal-title":"Nat Med."},{"key":"B54","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1097\/MED.0b013e328337282f","article-title":"Humanized mouse models to study human diseases","volume":"17","author":"Brehm","year":"2010","journal-title":"Curr Opin Endocrinol Diabetes Obes."},{"key":"B55","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1038\/nri3311","article-title":"Humanized mice for immune system investigation: progress, promise and challenges","volume":"12","author":"Shultz","year":"2012","journal-title":"Nat Rev Immunol."},{"key":"B56","doi-asserted-by":"publisher","first-page":"3466","DOI":"10.1158\/1538-7445.AM2015-261","article-title":"Nivolumab and urelumab enhance antitumor activity of human T lymphocytes engrafted in Rag2-\/-IL2R\u03b3null immunodeficient mice","volume":"75","author":"Sanmamed","year":"2015","journal-title":"Cancer Res."},{"key":"B57","doi-asserted-by":"publisher","first-page":"15756","DOI":"10.1038\/srep15756","article-title":"High efficacy vasopermeability drug candidates identified by screening in an ex ovo chorioallantoic membrane model","volume":"5","author":"Pink","year":"2015","journal-title":"Sci Rep."},{"key":"B58","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1016\/j.yexcr.2014.06.010","article-title":"The chick embryo chorioallantoic membrane as a model for tumor biology","volume":"328","author":"Ribatti","year":"2014","journal-title":"Exp Cell Res."},{"key":"B59","doi-asserted-by":"publisher","first-page":"9959","DOI":"10.3390\/ijms13089959","article-title":"Chick chorioallantoic membrane (CAM) assay as an in vivo model to study the effect of newly identified molecules on ovarian cancer invasion and metastasis","volume":"13","author":"Lokman","year":"2012","journal-title":"Int J Mol Sci."},{"key":"B60","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.reprotox.2016.11.004","article-title":"The chick embryo chorioallantoic membrane (CAM) assay","volume":"70","author":"Ribatti","year":"2017","journal-title":"Reprod Toxicol."},{"key":"B61","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1007\/s00418-008-0536-2","article-title":"Chick embryo chorioallantoic membrane model systems to study and visualize human tumor cell metastasis","volume":"130","author":"Deryugina","year":"2008","journal-title":"Histochem Cell Biol."},{"key":"B62","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.canlet.2012.07.023","article-title":"Tumor grafts derived from sarcoma patients retain tumor morphology, viability, and invasion potential and indicate disease outcomes in the chick chorioallantoic membrane model","volume":"326","author":"Sys","year":"2012","journal-title":"Cancer Lett."},{"key":"B63","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.mod.2016.05.003","article-title":"The chick embryo chorioallantoic membrane (CAM). a multifaceted experimental model","volume":"141","author":"Ribatti","year":"2016","journal-title":"Mech Dev."},{"key":"B64","doi-asserted-by":"publisher","first-page":"44686","DOI":"10.1038\/srep44686","article-title":"Development of bioluminescent chick chorioallantoic membrane (CAM) models for primary pancreatic cancer cells: a platform for drug testing","volume":"7","author":"Rovithi","year":"2017","journal-title":"Sci Rep."},{"key":"B65","first-page":"291","article-title":"The assay of angiogenesis","volume":"365","author":"Knighton","year":"1991","journal-title":"Prog Clin Biol Res."},{"key":"B66","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1023\/a:1026574416001","article-title":"Angiogenesis assays: problems and pitfalls","volume":"19","author":"Auerbach","year":"2000","journal-title":"Cancer Metastasis Rev."},{"key":"B67","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1590\/1414-431X20132647","article-title":"A spheroid-based 3-D culture model for pancreatic cancer drug testing, using the acid phosphatase assay","volume":"46","author":"Wen","year":"2013","journal-title":"Brazilian J Med Biol Res."},{"key":"B68","doi-asserted-by":"publisher","first-page":"e73345","DOI":"10.1371\/journal.pone.0073345","article-title":"Application of concave microwells to pancreatic tumor spheroids enabling anticancer drug evaluation in a clinically relevant drug resistance model","volume":"8","author":"Yeon","year":"2013","journal-title":"PLoS ONE."},{"key":"B69","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1038\/nature19768","article-title":"Tissue-specific mutation accumulation in human adult stem cells during life","volume":"538","author":"Blokzijl","year":"2016","journal-title":"Nature."},{"key":"B70","doi-asserted-by":"publisher","first-page":"1724","DOI":"10.1038\/nprot.2016.097","article-title":"Culture and establishment of self-renewing human and mouse adult liver and pancreas 3D organoids and their genetic manipulation","volume":"11","author":"Broutier","year":"2016","journal-title":"Nat Protoc."},{"key":"B71","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1016\/j.cell.2014.12.021","article-title":"Organoid models of human and mouse ductal pancreatic cancer","volume":"160","author":"Boj","year":"2015","journal-title":"Cell."},{"key":"B72","doi-asserted-by":"publisher","first-page":"475","DOI":"10.3389\/fonc.2019.00475","article-title":"Pancreatic cancer organoids for determining sensitivity to bromodomain and extra-terminal inhibitors (BETI)","volume":"9","author":"Bian","year":"2019","journal-title":"Front Oncol"},{"key":"B73","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.canlet.2017.09.016","article-title":"Speeding towards individualized treatment for pancreatic cancer by taking an alternative road","volume":"410","author":"Iovanna","year":"2017","journal-title":"Cancer Lett."},{"key":"B74","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1186\/s12885-018-4238-4","article-title":"Development of primary human pancreatic cancer organoids, matched stromal and immune cells and 3D tumor microenvironment models","volume":"18","author":"Tsai","year":"2018","journal-title":"BMC Cancer."},{"key":"B75","doi-asserted-by":"publisher","first-page":"3111","DOI":"10.1039\/C5LC90069G","article-title":"Bioprinting of 3D hydrogels","volume":"15","author":"Stanton","year":"2015","journal-title":"Lab Chip."},{"key":"B76","doi-asserted-by":"publisher","first-page":"014110","DOI":"10.1088\/1758-5082\/2\/1\/014110","article-title":"Biomatrices and biomaterials for future developments of bioprinting and biofabrication","volume":"2","author":"Nakamura","year":"2010","journal-title":"Biofabrication."},{"key":"B77","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1023\/B:BMMD.0000031751.67267.9f","article-title":"Biological laser printing: a novel technique for creating heterogeneous 3-dimensional cell patterns","volume":"6","author":"Barron","year":"2004","journal-title":"Biomed Microdevices."},{"key":"B78","doi-asserted-by":"publisher","first-page":"1325","DOI":"10.1089\/ten.2006.12.1325","article-title":"Direct freeform fabrication of seeded hydrogels in arbitrary geometries","volume":"12","author":"Cohen","year":"2006","journal-title":"Tissue Eng."},{"key":"B79","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1016\/0014-4827(88)90275-3","article-title":"Cytoscribing: a method for micropositioning cells and the construction of two- and three-dimensional synthetic tissues","volume":"179","author":"Klebe","year":"1988","journal-title":"Exp Cell Res."},{"key":"B80","doi-asserted-by":"publisher","first-page":"21","DOI":"10.5306\/wjco.v8.i1.21","article-title":"Three-dimensional bio-printing: a new frontier in oncology research","volume":"8","author":"Charbe","year":"2017","journal-title":"World J Clin Oncol."},{"key":"B81","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1016\/j.semcancer.2005.05.002","article-title":"Three-dimensional tissue culture models in cancer biology","volume":"15","author":"Kim","year":"2005","journal-title":"Semin Cancer Biol."},{"key":"B82","doi-asserted-by":"publisher","first-page":"035001","DOI":"10.1088\/1758-5082\/6\/3\/035001","article-title":"Three-dimensional printing of Hela cells for cervical tumor model in vitro","volume":"6","author":"Zhao","year":"2014","journal-title":"Biofabrication."},{"key":"B83","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1016\/j.tibtech.2015.06.007","article-title":"Bioprinting for cancer research","volume":"33","author":"Knowlton","year":"2015","journal-title":"Trends Biotechnol."},{"key":"B84","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/j.addr.2018.06.011","article-title":"3D bioprinting of functional tissue models for personalized drug screening and in vitro disease modeling","volume":"132","author":"Ma","year":"2018","journal-title":"Adv Drug Deliv Rev."},{"key":"B85","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1038\/nbt.2989","article-title":"Microfluidic organs-on-chips","volume":"32","author":"Bhatia","year":"2014","journal-title":"Nat Biotechnol."},{"key":"B86","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1002\/cpt.742","article-title":"Primary human lung alveolus-on-a-chip model of intravascular thrombosis for assessment of therapeutics","volume":"103","author":"Jain","year":"2018","journal-title":"Clin Pharmacol Ther."},{"key":"B87","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1016\/j.celrep.2017.09.043","article-title":"Human organ chip models recapitulate orthotopic lung cancer growth, therapeutic responses, and tumor dormancy in vitro","volume":"21","author":"Hassell","year":"2017","journal-title":"Cell Rep."},{"key":"B88","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1038\/s41568-018-0104-6","article-title":"Modelling cancer in microfluidic human organs-on-chips","volume":"19","author":"Sontheimer-Phelps","year":"2019","journal-title":"Nat Rev Cancer."},{"key":"B89","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1043\/1543-2165(2007)131[1027:BCAROC]2.0.CO;2","article-title":"Bronchioloalveolar carcinoma: a review of current concepts and evolving issues","volume":"131","author":"Yousem","year":"2007","journal-title":"Arch Pathol Lab Med."},{"key":"B90","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1007\/s12185-011-0949-x","article-title":"Targeting the interplay between myeloma cells and the bone marrow microenvironment in myeloma","volume":"94","author":"Abe","year":"2011","journal-title":"Int J Hematol."},{"key":"B91","doi-asserted-by":"publisher","first-page":"3626","DOI":"10.1039\/c1lc20325h","article-title":"Generation of oxygen gradients in microfluidic devices for cell culture using spatially confined chemical reactions","volume":"11","author":"Chen","year":"2011","journal-title":"Lab Chip."},{"key":"B92","doi-asserted-by":"publisher","first-page":"e0129593","DOI":"10.1371\/journal.pone.0129593","article-title":"Cancer associated fibroblast-derived hepatocyte growth factor inhibits the paclitaxel-induced apoptosis of lung cancer A549 cells by up-regulating the PI3K\/Akt and GRP78 signaling on a microfluidic platform","volume":"10","author":"Ying","year":"2015","journal-title":"PLoS ONE."},{"key":"B93","doi-asserted-by":"publisher","first-page":"4109","DOI":"10.1016\/j.biomaterials.2013.02.045","article-title":"Application of a microfluidic chip-based 3D co-culture to test drug sensitivity for individualized treatment of lung cancer","volume":"34","author":"Xu","year":"2013","journal-title":"Biomaterials."},{"key":"B94","doi-asserted-by":"publisher","first-page":"36603","DOI":"10.18632\/oncotarget.5464","article-title":"Identification of drugs as single agents or in combination to prevent carcinoma dissemination in a microfluidic 3D environment","volume":"6","author":"Bai","year":"2015","journal-title":"Oncotarget."},{"key":"B95","doi-asserted-by":"publisher","first-page":"1325","DOI":"10.1038\/s41598-017-01256-8","article-title":"A novel microfluidic 3D platform for culturing pancreatic ductal adenocarcinoma cells: comparison with in vitro cultures and in vivo xenografts","volume":"7","author":"Beer","year":"2017","journal-title":"Sci Rep."},{"key":"B96","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1177\/0300985811402846","article-title":"Swine as models in biomedical research","volume":"49","author":"Swindle","year":"2012","journal-title":"Vet Pathol."},{"key":"B97","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1016\/j.theriogenology.2016.04.058","article-title":"Pigs as models of human cancers","volume":"86","author":"Flisikowska","year":"2016","journal-title":"Theriogenology."},{"key":"B98","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1053\/j.gastro.2012.07.110","article-title":"A porcine model of familial adenomatous polyposis","volume":"143","author":"Flisikowska","year":"2012","journal-title":"Gastroenterology."},{"key":"B99","doi-asserted-by":"publisher","first-page":"e210","DOI":"10.1038\/oncsis.2016.19","article-title":"A porcine model of osteosarcoma","volume":"5","author":"Saalfrank","year":"2016","journal-title":"Oncogenesis."},{"key":"B100","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1007\/s00270-005-0099-8","article-title":"N-nitrosodiethylamine-induced pig liver hepatocellular carcinoma model: radiological and histopathological studies","volume":"29","author":"Li","year":"2006","journal-title":"Cardiovasc Intervent Radiol."},{"key":"B101","doi-asserted-by":"publisher","first-page":"190","DOI":"10.3389\/fonc.2017.00190","article-title":"The oncopig cancer model: an innovative large animal translational oncology platform","volume":"7","author":"Schachtschneider","year":"2017","journal-title":"Front Oncol."},{"key":"B102","doi-asserted-by":"publisher","first-page":"4178","DOI":"10.1158\/1538-7445","article-title":"Abstract 4178: Pigs as a new weapon against cancer: modeling solid tumors in porcine","volume":"76","author":"Diaz","year":"2016","journal-title":"Cancer Res"},{"key":"B103","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1177\/1091581812462039","article-title":"The minipig as nonrodent species in toxicology - Where are we now?","volume":"31","author":"Ganderup","year":"2012","journal-title":"Int J Toxicol."},{"key":"B104","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1208\/s12248-013-9482-6","article-title":"Assessment of juvenile pigs to serve as human pediatric surrogates for preclinical formulation pharmacokinetic testing","volume":"15","author":"Roth","year":"2013","journal-title":"AAPS J."},{"key":"B105","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1002\/wsbm.75","article-title":"In silico models of cancer","volume":"2","author":"Edelman","year":"2010","journal-title":"Wiley Interdiscip Rev Syst Biol Med."},{"key":"B106","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1056\/NEJMoa060096","article-title":"A five-gene signature and clinical outcome in non\u2013small-cell lung cancer","volume":"356","author":"Chen","year":"2007","journal-title":"N Engl J Med."},{"key":"B107","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/S1535-6108(02)00032-6","article-title":"Classification, subtype discovery, and prediction of outcome in pediatric acute lymphoblastic leukemia by gene expression profiling","volume":"1","author":"Yeoh","year":"2002","journal-title":"Cancer Cell."},{"key":"B108","doi-asserted-by":"publisher","first-page":"1665","DOI":"10.1200\/JCO.2005.03.9115","article-title":"Multicenter validation of a gene expression-based prognostic signature in lymph node-negative primary breast cancer","volume":"24","author":"Foekens","year":"2006","journal-title":"J Clin Oncol."},{"key":"B109","doi-asserted-by":"publisher","first-page":"2284","DOI":"10.1200\/JCO.2004.05.166","article-title":"Gene expression profiles predict complete pathologic response to neoadjuvant paclitaxel and fluorouracil, doxorubicin, and cyclophosphamide chemotherapy in breast cancer","volume":"22","author":"Ayers","year":"2004","journal-title":"J Clin Oncol."},{"key":"B110","doi-asserted-by":"publisher","first-page":"1839","DOI":"10.1200\/JCO.2005.04.7019","article-title":"Gene expression signature predicting pathologic complete response with gemcitabine, epirubicin, and docetaxel in primary breast cancer","volume":"24","author":"Thuerigen","year":"2006","journal-title":"J Clin Oncol."},{"key":"B111","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1158\/1078-0432.CCR-13-1943","article-title":"Modeling RAS phenotype in colorectal cancer uncovers novel molecular traits of RAS dependency and improves prediction of response to targeted agents in patients AC","volume":"20","author":"Guinney","year":"2014","journal-title":"Clin Cancer Res."},{"key":"B112","doi-asserted-by":"publisher","first-page":"2987","DOI":"10.1158\/0008-5472.CAN-14-3242","article-title":"Identification of prognostic groups in high-grade serous ovarian cancer treated with platinum-taxane chemotherapy","volume":"75","author":"Chen","year":"2015","journal-title":"Cancer Res."},{"key":"B113","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1038\/nature08506","article-title":"Predicting new molecular targets for known drugs","volume":"462","author":"Keiser","year":"2009","journal-title":"Nature."},{"key":"B114","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.1021\/ci060003g","article-title":"Prediction of biological targets for compounds using multiple-category bayesian models trained on chemogenomics databases","volume":"46","author":"Nidhi","year":"2006","journal-title":"J Chem Inf Model."},{"key":"B115","doi-asserted-by":"publisher","first-page":"W219","DOI":"10.1093\/nar\/gkl114","article-title":"TarFisDock: a web server for identifying drug targets with docking approach","volume":"34","author":"Li","year":"2006","journal-title":"Nucleic Acids Res."},{"key":"B116","doi-asserted-by":"publisher","first-page":"2440","DOI":"10.1021\/ci200192v","article-title":"Identifying compound-target associations by combining bioactivity profile similarity search and public databases mining","volume":"51","author":"Cheng","year":"2011","journal-title":"J Chem Inf Model."},{"key":"B117","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.csbj.2016.04.004","article-title":"Computational approaches in target identification and drug discovery","volume":"14","author":"Katsila","year":"2016","journal-title":"Comput Struct Biotechnol J."},{"key":"B118","doi-asserted-by":"publisher","first-page":"e0149896","DOI":"10.1371\/journal.pone.0149896","article-title":"Prediction of candidate drugs for treating pancreatic cancer by using a combined approach","volume":"11","author":"Ma","year":"2016","journal-title":"PLoS ONE."},{"key":"B119","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.coph.2018.08.007","article-title":"In silico models in drug development: where we are","volume":"42","author":"Pi\u00f1ero","year":"2018","journal-title":"Curr Opin Pharmacol."},{"key":"B120","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1038\/clpt.2013.181","article-title":"Network medicine in disease analysis and therapeutics","volume":"94","author":"Chen","year":"2013","journal-title":"Clin Pharmacol Ther."},{"key":"B121","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1038\/nbt.3161","article-title":"Drugging the gut microbiome","volume":"33","author":"Garber","year":"2015","journal-title":"Nat Biotechnol."},{"key":"B122","doi-asserted-by":"publisher","first-page":"247","DOI":"10.4155\/fmc.14.5","article-title":"Computational target fishing: what should chemogenomics researchers expect for the future of In silico drug design and discovery?","volume":"6","author":"Wang","year":"2014","journal-title":"Future Med Chem."}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fonc.2019.01443\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,1,22]],"date-time":"2020-01-22T05:48:59Z","timestamp":1579672139000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fonc.2019.01443\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1,22]]},"references-count":122,"alternative-id":["10.3389\/fonc.2019.01443"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2019.01443","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,1,22]]},"article-number":"1443"}}